APA (7th ed.) Citation

Majerus, E. M., Ataga, K. I., Vichinsky, E., Eaton, C. A., Mazanet, R., Nathan, D. G., & Field, J. J. (2014). NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial. Blood, 124(21), 2718. https://doi.org/10.1182/blood.V124.21.2718.2718

Chicago Style (17th ed.) Citation

Majerus, Elaine M., Kenneth I. Ataga, Elliott Vichinsky, Cheryl A. Eaton, Rosemary Mazanet, David G. Nathan, and Joshua J. Field. "NKTT120 Reduces INKT Cells Without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial." Blood 124, no. 21 (2014): 2718. https://doi.org/10.1182/blood.V124.21.2718.2718.

MLA (9th ed.) Citation

Majerus, Elaine M., et al. "NKTT120 Reduces INKT Cells Without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial." Blood, vol. 124, no. 21, 2014, p. 2718, https://doi.org/10.1182/blood.V124.21.2718.2718.